Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Martin McMahon
University of Utah, Department: Dermatology
Should you be removed from our database? Contact us at [email protected]. Read more below.
University of California San Francisco
Intellectual property rights (e.g., royalties, patents, copyrights) not from the awardee Institution
The investigator receives royalty payments from the BRaf(CAT) mouse, which will be used in this study.
Targeting Oncogenic BRAF And PI3'-Kinase Signaling For Melanoma Therapy
Melanoma is an increasingly common and highly aggressive form of cancer diagnosed in ~132,000 patients and responsible for ~20,000 deaths per year worldwide. Recently a new drug, vemurafenib, has shown great promise in the treatment of the ~50% of patients whose melanoma is driven by a mutated BRAF oncogene. Leveraging the success of vemurafenib, we propose here to employ state-of-the-art experimental systems to design and evaluate new, rationally targeted combination therapeutic strategies with the long-term goal of curing patients with melanoma.
Filed on March 31, 2016.
Tell us what you know about Martin McMahon's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Martin McMahon”
Name | Institution | Type | Company | Disclosed Value |
---|---|---|---|---|
Martin McMahon | University of Utah | Conflict of Interest | Genentech | $10,000 - $19,999 |
Martin McMahon | University of Utah | Conflict of Interest | #N/A | $10,000-19,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.